Medical Regulatory Compliance — CE, FDA, UKCA, MHRA, and Beyond

Chapter 01

Why we treat regulatory as a design constraint, not a final check

The most expensive regulatory failures we see in the market are not deliberate non-compliance — they are documentation gaps discovered too late: at customs, at installation, or after a post-market event. By that point the cost of fixing is multiples of the cost of preventing.

Our model treats regulatory compliance as a design constraint at the front of every procurement engagement. We map the destination-market regulatory pathway before we issue an RFQ, we pre-clear documentation before the cargo leaves origin, and we maintain post-market vigilance against the installed base.

Chapter 04

FDA compliance for US-bound supply

For supply into the United States, FDA premarket clearance is the gateway: 510(k) for most Class II devices, PMA for Class III, and De Novo or 510(k)-exempt routes where applicable. We confirm the 510(k) / PMA number, the manufacturer's FDA establishment registration, and the device listing.

We also screen against FDA import alerts and FDA warning letters before shipping into the US — being on either list materially complicates import.

Chapter 07

Post-market obligations

Regulatory compliance does not end at delivery. Adverse events have to be reported, complaints handled, recalls executed, and post-market surveillance signals fed back to the manufacturer. Our QMS includes the workflows that make this manageable — see the Quality Assurance page for the operational detail.